SERUM NITRATE LEVELS IN ULCERATIVE-COLITIS AND CROHNS-DISEASE

被引:74
作者
POOL, MO
BOUMA, G
VISSER, JJ
KOLKMAN, JJ
TRAN, DD
MEUWISSEN, SGM
PENA, AS
机构
[1] FREE UNIV AMSTERDAM HOSP, DEPT GASTROENTEROL, 1081 HV AMSTERDAM, NETHERLANDS
[2] FREE UNIV AMSTERDAM HOSP, DEPT CLIN CHEM, 1081 HV AMSTERDAM, NETHERLANDS
[3] FREE UNIV AMSTERDAM HOSP, DEPT SURG, 1081 HV AMSTERDAM, NETHERLANDS
关键词
ACTIVITY INDEX; CROHNS DISEASE; DIAGNOSTIC MARKER; INFLAMMATORY BOWEL DISEASE; NITRIC OXIDE; SERUM NITRATE CONCENTRATION; ULCERATIVE COLITIS;
D O I
10.3109/00365529509096328
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Nitric oxide is an important mediator in inflammatory and autoimmune-mediated tissue destruction and may be of pathophysiologic importance in inflammatory bowel disease. We studied whether serum levels of nitrate, the stable end-product of nitric oxide, are increased in active Crohn's disease or ulcerative colitis, in comparison with quiescent disease and healthy controls. The setting was the gastroenterology unit of the Free University Hospital, Amsterdam. Methods: In 146 patients-75 with ulcerative colitis and 71 with Crohn's disease-and 33 controls serum nitrate was measured by the Griess reaction after enzymatic conversion of nitrate to nitrite with nitrate reductase. Results: Median serum nitrate concentrations did not differ statistically significantly between ulcerative colitis (median, 34.2 mu mol/l; range, 15.6-229.4 mu mol/l), Crohn's disease (median 32.3 mu mol/l; range 13.2-143.2 mu mol/l), and healthy controls (median, 28.7 mu mol/l; range, 13.0-108.4 mu mol/l). However, when active ulcerative colitis patients (median, 44 mu mol/l; range, 29.1-229.4 mu mol/l were compared with inactive ulcerative colitis patients (median, 31.2 mu mol/l; range, 15.6-59.7 mu mol/l), a significant difference in nitrate concentration was found (p < 0.0001). A significant positive correlation was found between serum nitrate levels in ulcerative colitis and erythrocyte sedimentation rate (ESR) (r = 0.30, p = 0.01), leucocyte count (r = 0.27, p = 0.02), and thrombocyte count (r = 0.24, p = 0.04). Comparing active Crohn's disease patients (median, 37.5 mu mol/l; range, 13.2-143.2 mu mol/l) with inactive Crohn's disease patients (median, 31.3 mu mol/l; range, 14.5-92.3 mu mol/l) also showed a significant difference in serum nitrate concentration (p < 0.009). Serum nitrate levels correlated with the ESR (r = 0.26, p = 0.028) and serum albumin (r = -0.38, p = 0.004) as well. Conclusion: Nitric oxide production is increased in both active ulcerative colitis and Crohn's disease and may be implicated in the pathogenesis of inflammatory bowel disease.
引用
收藏
页码:784 / 788
页数:5
相关论文
共 35 条
[1]  
Moncada S., Palmer R.M.J., Higgs E.A., Nitric oxide: physiology, pathophysiology, and pharmacology, Pharmacol Rev, 43, pp. 109-142, (1991)
[2]  
Kolb H., Kolb-Bachofen V., Nitric oxide: a pathogenetic factor in autoimmunity, Immunol Today, 13, pp. 157-160, (1992)
[3]  
Mc Naughton W.K., Cirino G., Wallace J.L., Endothelium-derived relaxing factor (NO) has protective actions in the stomach, Life Sci, 4589, pp. 1869-1876, (1989)
[4]  
Hutcheson I.R., Whittle J.R.B., Boughton-Smith N.K., Role of NO in maintaining vascular integrity in endotoxin-induced acute intestinal damage in the rat, Br J Pharmacol, 101, pp. 815-820, (1990)
[5]  
Tam F.S., Hillier K., The role of NO in mediating non-adrenergic non-cholinergic relaxation in longitudinal muscle of human tania coli, Life Sci, 51, pp. 1277-1284, (1992)
[6]  
Moncada S., Higgs A., The L-arginine-nitric oxide pathway, N Engl J Med, 329, pp. 2002-2012, (1993)
[7]  
Kitagawa H., Takeda F., Kohei H., Effect of endothelium-derived relaxing factor on the gastric laesion induced by HCI in rats, J Pharmacol Exp Ther, 253, pp. 1133-1137, (1990)
[8]  
Cunha F.A., Moncada S., Liew F.Y., IL-10 inhibits induction of nitric oxide synthase by IFN-alpha in murine macrophages, Biochem Biophys Res Commun, 182, pp. 1155-1159, (1992)
[9]  
Estrada C., Gomez C., Martin C., Moncada S., Gonzalez C., Nitric oxide mediates TNF alpha cytotoxicity in endothelial cells, Biochem Biophys Res Commun, 186, pp. 475-482, (1992)
[10]  
Leaf F.D., Wishnok J.S., Tannenbaum S.R., Nitric oxide: the dark side, Nitric oxide from L-arginine: a bioregulatory system, pp. 291-299, (1990)